Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates

Company Performance - Outset Medical, Inc. reported a quarterly loss of $3.24 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.97, representing an earnings surprise of -234.02% [1] - The company posted revenues of $29.75 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 7.49%, and showing an increase from $28.17 million in the same quarter last year [2] - Over the last four quarters, Outset Medical has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Outset Medical shares have declined approximately 30.7% since the beginning of the year, in contrast to the S&P 500's decline of -4.7% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.95 on revenues of $29.5 million, and for the current fiscal year, it is -$3.92 on revenues of $120.09 million [7] Industry Outlook - The Medical Info Systems industry, to which Outset Medical belongs, is currently ranked in the top 27% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]